Prestige Consumer Healthcare (PBH) Treasury Shares (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Treasury Shares of $438.5 million for Q4 2025, up 64.96% year-over-year from $265.8 million in Q4 2024, and up 11.81% quarter-over-quarter from $392.2 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Treasury Shares (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Treasury Shares history runs 15 years deep, the most recent figure standing at $438.5 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 64.96% year-over-year to $438.5 million; the TTM figure through Dec 2025 stood at $438.5 million (up 64.96% YoY), while the FY2025 annual figure was $277.2 million, up 26.22% from the prior year.
- Treasury Shares for Q4 2025 stood at $438.5 million, up from $392.2 million in the prior quarter.
- The five-year high for Treasury Shares was $8.9 million in Q4 2025, with the low at $4.1 million in Q1 2021.
- The 5-year median for Treasury Shares is $5.7 million (2023), against an average of $5.7 million.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares grew 2.23% in 2022, then surged 64.96% in 2025.
- Prestige Consumer Healthcare's Treasury Shares stood at $133.6 million in 2021, then soared by 41.5% to $189.1 million in 2022, then climbed by 16.14% to $219.6 million in 2023, then climbed by 21.04% to $265.8 million in 2024, then soared by 64.96% to $438.5 million in 2025.
- Business Quant data shows PBH's Treasury Shares at $438.5 million in Q4 2025, $392.2 million in Q3 2025, and $316.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | 8.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 439.30 Mn |
| Mar 31, 2026 | 8.89 Mn |
| Mar 31, 2026 | 439.30 Mn |
| Mar 31, 2026 | 8.89 Mn |
| Dec 31, 2025 | 438.55 Mn |
| Dec 31, 2025 | 438.55 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Mar 31, 2025 | 6.50 Mn |